PE20180198A1 - Sistemas terapeuticos transdermicos con lamina de proteccion (release liner) inhibidora de la cristalizacion - Google Patents
Sistemas terapeuticos transdermicos con lamina de proteccion (release liner) inhibidora de la cristalizacionInfo
- Publication number
- PE20180198A1 PE20180198A1 PE2017001638A PE2017001638A PE20180198A1 PE 20180198 A1 PE20180198 A1 PE 20180198A1 PE 2017001638 A PE2017001638 A PE 2017001638A PE 2017001638 A PE2017001638 A PE 2017001638A PE 20180198 A1 PE20180198 A1 PE 20180198A1
- Authority
- PE
- Peru
- Prior art keywords
- release liner
- transdermal therapeutic
- therapeutic systems
- crystalization
- inhibitor sheet
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 abstract 3
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010040299A DE102010040299A1 (de) | 2010-09-06 | 2010-09-06 | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20180198A1 true PE20180198A1 (es) | 2018-01-26 |
Family
ID=44653285
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2017001638A PE20180198A1 (es) | 2010-09-06 | 2011-09-02 | Sistemas terapeuticos transdermicos con lamina de proteccion (release liner) inhibidora de la cristalizacion |
| PE2013000383A PE20131138A1 (es) | 2010-09-06 | 2011-09-02 | Sistemas terapeuticos transdermicos con lamina de proteccion (release liner) inhibidora de la cristalizacion |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013000383A PE20131138A1 (es) | 2010-09-06 | 2011-09-02 | Sistemas terapeuticos transdermicos con lamina de proteccion (release liner) inhibidora de la cristalizacion |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US8557279B2 (https=) |
| EP (1) | EP2613771A1 (https=) |
| JP (2) | JP6104800B2 (https=) |
| KR (1) | KR20130114127A (https=) |
| CN (1) | CN103079549B (https=) |
| AP (1) | AP3586A (https=) |
| AR (1) | AR082907A1 (https=) |
| AU (1) | AU2011298892B2 (https=) |
| BR (1) | BR112013005305A2 (https=) |
| CA (1) | CA2810103C (https=) |
| CL (1) | CL2013000636A1 (https=) |
| CO (1) | CO6690753A2 (https=) |
| CR (1) | CR20130098A (https=) |
| CU (1) | CU24172B1 (https=) |
| DE (1) | DE102010040299A1 (https=) |
| DO (1) | DOP2013000053A (https=) |
| EA (1) | EA032575B1 (https=) |
| EC (1) | ECSP13012477A (https=) |
| GT (1) | GT201300062A (https=) |
| IL (2) | IL224980A (https=) |
| MA (1) | MA34581B1 (https=) |
| MX (1) | MX2013002602A (https=) |
| MY (1) | MY162768A (https=) |
| NZ (1) | NZ607630A (https=) |
| PE (2) | PE20180198A1 (https=) |
| PH (1) | PH12013500429A1 (https=) |
| SG (2) | SG187941A1 (https=) |
| TN (1) | TN2013000087A1 (https=) |
| TW (1) | TWI576245B (https=) |
| UA (1) | UA110217C2 (https=) |
| UY (1) | UY33590A (https=) |
| WO (1) | WO2012031985A1 (https=) |
| ZA (1) | ZA201301389B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI541246B (zh) | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH674618A5 (https=) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
| HU210549B (en) * | 1988-10-27 | 1995-05-29 | Schering Ag | Process for producing transdermally applicable pharmaceutical composition containing gestodene |
| MX9101787A (es) | 1990-10-29 | 1992-06-05 | Alza Corp | Formulaciones,metodos y dispositivos anticonceptivos transdermicos |
| US5512292A (en) | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| DE4210711A1 (de) | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
| DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE4405899A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Desogestrel |
| DE4405898A1 (de) | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| DE19629468A1 (de) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermale therapeutische Systeme |
| DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| KR100758757B1 (ko) | 1999-11-24 | 2007-09-14 | 애자일 쎄라퓨틱스, 인크. | 개량된 경피적 피임제 송달시스템 및 송달방법 |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| US20020106402A1 (en) | 2000-12-05 | 2002-08-08 | Hartwig Rod Lawson | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| EP1216699A1 (de) | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsystem enthaltend ein hochpotentes Gestagen |
| US20030165547A1 (en) * | 2001-05-18 | 2003-09-04 | Elisabeth Picard-Lesboueyries | Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA |
| DE10261696A1 (de) * | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
| WO2004073696A1 (de) * | 2003-02-21 | 2004-09-02 | Schering Ag | Uv-stabiles transdermales pflaster |
| UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
| US8668925B2 (en) * | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| CA2549916C (en) * | 2003-12-12 | 2013-09-17 | Schering Aktiengesellschaft | Transdermal delivery system of hormones without penetration enhancers |
| TW200628175A (en) * | 2004-10-08 | 2006-08-16 | Noven Pharma | Transdermal drug delivert device including an occlusive backing |
| DE102004062182B4 (de) | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff |
| US8962013B2 (en) * | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| DE102005050729A1 (de) | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| EP2349230A2 (en) * | 2008-10-06 | 2011-08-03 | Mylan Technologies, Inc. | Amorphous rotigotine transdermal system |
-
2010
- 2010-09-06 DE DE102010040299A patent/DE102010040299A1/de not_active Withdrawn
-
2011
- 2011-02-09 UA UAA201304320A patent/UA110217C2/ru unknown
- 2011-09-02 SG SG2013013453A patent/SG187941A1/en unknown
- 2011-09-02 MX MX2013002602A patent/MX2013002602A/es active IP Right Grant
- 2011-09-02 EA EA201390246A patent/EA032575B1/ru not_active IP Right Cessation
- 2011-09-02 MY MYPI2013700339A patent/MY162768A/en unknown
- 2011-09-02 WO PCT/EP2011/065204 patent/WO2012031985A1/de not_active Ceased
- 2011-09-02 CA CA2810103A patent/CA2810103C/en active Active
- 2011-09-02 JP JP2013526490A patent/JP6104800B2/ja not_active Expired - Fee Related
- 2011-09-02 PE PE2017001638A patent/PE20180198A1/es not_active Application Discontinuation
- 2011-09-02 EP EP11757808.8A patent/EP2613771A1/de not_active Withdrawn
- 2011-09-02 PE PE2013000383A patent/PE20131138A1/es not_active Application Discontinuation
- 2011-09-02 AU AU2011298892A patent/AU2011298892B2/en not_active Ceased
- 2011-09-02 BR BR112013005305A patent/BR112013005305A2/pt not_active Application Discontinuation
- 2011-09-02 AP AP2013006787A patent/AP3586A/xx active
- 2011-09-02 MA MA35706A patent/MA34581B1/fr unknown
- 2011-09-02 CN CN201180042701.6A patent/CN103079549B/zh not_active Expired - Fee Related
- 2011-09-02 PH PH1/2013/500429A patent/PH12013500429A1/en unknown
- 2011-09-02 SG SG10201506927TA patent/SG10201506927TA/en unknown
- 2011-09-02 NZ NZ607630A patent/NZ607630A/en not_active IP Right Cessation
- 2011-09-02 KR KR1020137008726A patent/KR20130114127A/ko not_active Ceased
- 2011-09-02 CU CU20130031A patent/CU24172B1/es active IP Right Grant
- 2011-09-05 UY UY0001033590A patent/UY33590A/es unknown
- 2011-09-06 TW TW100132149A patent/TWI576245B/zh not_active IP Right Cessation
- 2011-09-06 US US13/225,660 patent/US8557279B2/en not_active Expired - Fee Related
- 2011-09-06 AR ARP110103250A patent/AR082907A1/es unknown
-
2013
- 2013-02-22 ZA ZA2013/01389A patent/ZA201301389B/en unknown
- 2013-02-28 IL IL224980A patent/IL224980A/en not_active IP Right Cessation
- 2013-03-05 TN TNP2013000087A patent/TN2013000087A1/fr unknown
- 2013-03-06 CL CL2013000636A patent/CL2013000636A1/es unknown
- 2013-03-06 CR CR20130098A patent/CR20130098A/es unknown
- 2013-03-06 DO DO2013000053A patent/DOP2013000053A/es unknown
- 2013-03-06 EC ECSP13012477 patent/ECSP13012477A/es unknown
- 2013-03-06 CO CO13045117A patent/CO6690753A2/es unknown
- 2013-03-06 GT GT201300062A patent/GT201300062A/es unknown
- 2013-09-17 US US14/028,990 patent/US9060955B2/en not_active Expired - Fee Related
-
2016
- 2016-08-22 JP JP2016161929A patent/JP2016216500A/ja active Pending
-
2017
- 2017-03-13 IL IL251124A patent/IL251124B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX385291B (es) | Dispensador de composiciones volátiles. | |
| CL2012003281A1 (es) | Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica. | |
| ECSP13012394A (es) | Nuevas formas de dosificación de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa | |
| CL2017001952A1 (es) | Composiciones estables de povidona-yodo con esteroides o antiinflamatorios no esteroideos (divisional solicitud 592-2014) | |
| CL2013000423A1 (es) | Forma de dosificacion farmaceutica con resistencia a rompimiento de al menos 500 n, que contiene un ingrediente activo, un polisacarido anionico y un oxido de polialquileno, en donde el ingrediente activo esta presente en una matriz de liberacion controlada comprendiendo el polisacarido anionico y el oxido de polialquileno. | |
| BR112012019529A2 (pt) | inibidores de d-nitrosoglutationa redutase | |
| AR066100A1 (es) | Base de anclaje para fijacion de equipos bancarios | |
| CL2013000424A1 (es) | Forma de dosificacion farmaceutica resistente al rompimiento que comprende a) un ingrediente farmacologicamente activo, b) un polimero, c) un oxido de polialquileno, donde a) esta presente en una matriz de liberacion controlada que comprende b) y c). | |
| MX343669B (es) | Combinacion de inhibidores de la cinasa de control 1 inhibidores de la cinasa wee 1. | |
| CR20110110A (es) | Composicion farmaceutica | |
| CY1122113T1 (el) | Φαρμακευτικες συνθεσεις για τη θεραπεια του ελικοβακτηριδιου του πυλωρου | |
| GT201200293A (es) | Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs) | |
| EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
| BR112014020113A8 (pt) | Composições farmacêuticas e método para diminuir a frequência de micção | |
| BR112017013255A2 (pt) | emplastro em gel | |
| CY1123202T1 (el) | Σκευασμα υδροκορτιζονης ελεγχομενης απελευθερωσης | |
| AR094289A1 (es) | Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol | |
| MX2020003662A (es) | Sistema terapeutico transdermico para la administracion transdermica de guanfacina que comprende un polimero hibrido acrilico de silicona. | |
| CL2008003799A1 (es) | Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis. | |
| TR201010683A1 (tr) | Vildagliptin formülasyonları. | |
| PE20180198A1 (es) | Sistemas terapeuticos transdermicos con lamina de proteccion (release liner) inhibidora de la cristalizacion | |
| UY33305A (es) | Compuestos heterocíclicos inhibidores de DGAT1 | |
| ECSP15050273A (es) | Formulación oral para el tratamiento de enfermedades cardiovasculares | |
| BR112013016998A2 (pt) | emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio | |
| MX2014001196A (es) | Reductores de agua de medio rango (mrwr) para hormigon. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |